• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Wolfe Research initiated coverage on MoonLake Immunotherapeutics with a new price target

    2/15/24 6:41:21 AM ET
    $MLTX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $MLTX alert in real time by email
    Wolfe Research initiated coverage of MoonLake Immunotherapeutics with a rating of Outperform and set a new price target of $77.00
    Get the next $MLTX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MLTX

    DatePrice TargetRatingAnalyst
    5/19/2025$61.00Peer Perform → Outperform
    Wolfe Research
    3/18/2025$67.00Outperform
    RBC Capital Mkts
    1/17/2025$62.00 → $82.00Neutral → Buy
    Goldman
    11/5/2024$92.00 → $73.00Outperform
    Wedbush
    8/26/2024Outperform → Peer Perform
    Wolfe Research
    6/25/2024$104.00Outperform
    Oppenheimer
    4/2/2024$62.00Neutral
    Goldman
    2/15/2024$77.00Outperform
    Wolfe Research
    More analyst ratings

    $MLTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Bvf Partners L P/Il

      4 - MoonLake Immunotherapeutics (0001821586) (Issuer)

      6/9/25 7:16:08 PM ET
      $MLTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Sturge Simon

      4 - MoonLake Immunotherapeutics (0001821586) (Issuer)

      6/9/25 9:08:48 AM ET
      $MLTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Loy Spike

      4 - MoonLake Immunotherapeutics (0001821586) (Issuer)

      6/9/25 9:07:53 AM ET
      $MLTX
      Biotechnology: Pharmaceutical Preparations
      Health Care